Halozyme (NASDAQ:HALO) has raised its financial guidance estimates for 2025 based on expected strong sales of products ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today provided a financial update, reiterating full ...

Analyst Jason Butler of JMP Securities reiterated a Buy rating on Halozyme (HALO – Research Report), retaining the price target of $73.00.Stay ...

EST Halozyme (HALO) announces new $250M accelerated share repurchase plan Stay Ahead of the Market:Discover outperforming stocks and ...

Industry executive with more than 25 years of finance and strategic leadership experienceBOSTON and SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage ...

SpringWorks Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

Halozyme Therapeutics stock is trading -17.97% below its average target price of $64.12 after marking a 2.8% during today's morning session. Analysts are giving the Mid-Cap Biotechnology company an ...

MSC Meraviglia is spending an extra night in Port Canaveral, Florida, and skipping its planned call on Ocean Cay, Bahamas, due to bad weather.

The traditional carnival-like "Ragoutsaria" celebration is wrapping up today, January 8, in the city of Kastoria, northern Greece, seeing locals donning colorful costumes and dancing in the streets of ...